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195* Bronchoalveolar lavage (BAL) ﬁndings in symptomatic
preschool children with and without CF
K. De Boeck1, N. Feyaert1, M. Proesmans1. 1University Hospital Leuven,
Pediatric Pulmonology, Leuven, Belgium
Neutrophilic lung infection and inﬂammation are typical for CF but have also
been reported in preschool children with recurrent wheeze. We therefore compared
BAL results in 143 symptomatic preschool (<5 y) children: CF and persistent lung
infection (n = 19), recurrent lung infection without wheeze (LI) (n = 77), recurrent
lung infection with persistent wheeze (WH) (n = 47). Medians and IQR are reported;
for group comparison Kruskal–Wallis was used.
Results: Total cell count (×103/ml) was higher (P< 0.001) in CF 1323 (430–2200)
than LI 176 (100–311) and WH 207 (120–437); % neutrophils was also higher
(p< 0.001) in CF 87% (72−92) than in RI 16% (4−38) and WH 23% (8−56).
% eosinophils was <1 in all groups and did not differ between LI and WH.
% macrophages was lower in CF 9 (5−20) than in RI 64 (42−84) and WH 56
(29−78) but lipid laden macrophage index was higher (p = 0.007) in CF 132 (100–
175) than RI 68 (44–105) and WH 68 (50−98). BAL cultures were +ve for S. aureus
in 42% of CF (p< 0.01) compared to 4% of RI and 8% of WH. H. inﬂuenzae was
present in 16% of CF, 21% of RI, and 11% of WH. S. pneumoniae was present in
0% of CF, 13% of LI, 4% of WH. P. aeruginosa was not isolated.
Conclusion: Symptomatic preschool children with CF have higher BAL total cell
counts due to marked increase in neutrophils compared to children with LI and
WH. In CF cultures are more often positive with S. aureus prevailing. Eosinophilia
is not detected in BAL, not even in group WH. Absolute macrofage count is similar
in all groups but lipid laden macrophage index in higher in CF children suggesting
that recurrent aspiration may be associated with their persistent symptoms.
196* Microbiological yield of induced sputum vs throat swab in
CF patients unable to produce spontaneous sputum
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A. Gomez1, N. Martinez1, B. Matı´a1, G. de la Fuente1, E. Lopez de Santamarı´a1,
B. Galdiz1, J. Barron1. 1Hospital Cruces, Barakaldo, Spain
We obtained an induced sputum sample (i.s.) in 175 (90%) times out of 193
inductions in 50 CF patients aged 11.7 (5−18) unable to produce spontaneous
sputum (s.s.).
Protocol:
1. throat swab (t.s.) after voluntary cough,
2. Spirometry and b2-agonist inhalation,
3. Sputum induction by nebulising 3% saline with a DeVilbiss Ultraneb,
4. Spirometry.
The quality of i.s. samples was assessed following the Murray criteria and compared
with that of s.s. in our CF patients.
Results: Pathogenic bacteria grew in 79 (45%) i.s. vs 43 (25%) t.s. (p< 0.01).
Fungal cultures were (+) in 46 (26%) i.s. vs 3 (2%) t.s. (p< 0.001). There was
bacteriological concordance in 107 (61%). Staphylococcus aureus (S.a.) grew in
48 (28%) i.s. vs 27 (15%) t.s. (p< 0.05). Stenotrophomonas maltophilia (S.m.)
in 18 i.s. vs 8 t.s. (p< 0.05). Pseudomonas aeruginosa grew in 21 i.s vs 12 t.s.
(n.s.). In 15 it grew in i.s. only vs 6 in t.s. only. There were >25 PMNs/ﬁeld in
48 (28.5%) i.s. vs 170 (77%) s.s. (p< 0.001), and >10 epithelial cells/ﬁeld (upper
airway contamination marker) in 89 (52%) i.s. vs 132 (60%) s.s. (ns). No patient
developed clinically signiﬁcant bronchoconstriction.
Conclusions: Sputum induction is a simple, feasible, well tolerated technique which
can be successful in most CF patients older than 5 unable to produce a s.s. Its
sensitivity for the recovery of any bacteria, fungi, S.a., and S.m. is higher than
that of t.s. The frequency of contamination with upper airways secretions was
similar in i.s. and s.s. The greater number of s.s. with >25 PMNs/ﬁeld is probably
due to the presence of higher lower airways inﬂammation in CF patients able
to produce s.s. Sputum induction should be used more frequently in CF. Further
research is warranted.
197* Detection of viruses in pulmonary exacerbations in CF
I. De Schutter1, E. De Wachter1, F. Van Ginderdeuren1, S. Vanlaethem1,
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Aims: To evaluate the involvement of viruses in CF pulmonary exacerbations and
to identify the main viral pathogens.
Methods: Respiratory viruses were searched for, at the onset of any acute pul-
monary exacerbation, in respiratory secretions obtained by nasal wash or broncho-
alveolar lavage (BAL) using multiplex-PCR and culture, and potentially blood for
viral serology.
Results: For 199 acute pulmonary exacerbations in 86 CF-patients (median age =
11 y 4m, sex ratio: F/M= 42/44), a viral pathogen was detected in 64/199 (32.2%)
episodes and in 3/64 episodes 2 viruses were found. The 3 main viral pathogens
were inﬂuenza A virus, respiratory syncitial virus and human metapneumovirus,
respectively found in 15, 15 and 8 episodes. In 56/64 (87.5%) episodes the viral
pathogen was detected on respiratory secretions (nasal wash: 52×, BAL: 4×) and
only in 9/30 (30%) by serology. Common viruses were found in all ages, however
inﬂuenza A was mostly detected in adults (in 11/24 = 45.8%) whereas RSV was
more present in the 0−2 yrs old (in 7/14 = 50%).
Conclusions: Common respiratory viruses seem to play a role in an unexpected high
proportion (32%) of pulmonary exacerbations in CF-patients of all age groups. PCR
and culture on respiratory secretions obtained by nasal wash is a rapid, sensitive
and non-invasive method for viral detection compared to serology.
198 Clinical features of Swine Flu in a major adult CF unit in London
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Hospital, Department of Cystic Fibrosis, London, United Kingdom; 2Imperial
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Introduction: In the Swine Flu (SF) pandemic, UK guidelines advised that patients
sought antiviral treatment after telephone discussion. In July 2009, we set up a
Triage Service for an adult unit serving approximately 600 patients to provide
advice and monitoring beyond antiviral therapy alone.
Methods: An information letter was distributed to all patients that included
UK screening criteria for suspected SF (fever, cough, myalgia, vomiting/nausea,
headache, rhinorrhoea) and a dedicated phone number. Risk stratiﬁcation, based
on baseline FEV1, resting O2 saturations and exacerbation frequency, was used to
advise either home treatment with antibiotics and antivirals, or hospital review.
Results: During the period 3rd July 2009 − 16th January 2010, 165 calls were
received: 98 for advice and 67 with symptoms. 29/67 (43%) calls and a further 2
direct referrals resulted in hospital review with the following outcomes: 20 (65%)
admissions; 21 (68%) given antivirals (20 Oseltamivir, 1 Zanamivir); 28 (90%)
given antibiotics (19 intravenous); SF-conﬁrmation via antigen/antibody testing or
PCR in 11 cases. Cases of conﬁrmed vs non-conﬁrmed SF showed increased fever
(82% vs 41%), headache (73% vs 20%), raised CRP (94mg/l vs 52mg/l), lower
neutrophil counts (5.5 vs 9.4×109/ml) and increased length of stay (10d vs 4d).
Sputum showed patients’ usual microbiology. There were no ITU admissions or
deaths.
Conclusions: Our Triage Service was able to effectively risk-stratify patients, admit-
ting those at highest risk for comprehensive in-patient care including intravenous
therapy. SF was a mild illness for the majority, with fever and headache most
discriminatory in those who attended.
